Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | JK08 |
Synonyms | |
Therapy Description |
Limited information is currently available on JK08, a putative fusion protein comprised of the IL-15/IL15Ralpha complex and an anti-CTLA4 antibody (Dec 2022). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
JK08 | JK-08|JK 08 | CTLA4 Antibody 24 | Limited information is currently available on JK08, a putative fusion protein comprised of the IL-15/IL15Ralpha complex and an anti-CTLA4 antibody (Dec 2022). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05620134 | Phase Ib/II | JK08 | A Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, in Patients With Unresectable Locally Advanced or Metastatic Cancer | Recruiting | ESP | BEL | 0 |